Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Secondary Abdominoplasty: Management of the Umbilicus after Prior Stalk Transection.

Dean RA, Dean JA, Matarasso A.

Plast Reconstr Surg. 2019 Apr;143(4):729e-733e. doi: 10.1097/PRS.0000000000005415.

PMID:
30921121
2.

Adaptation of the robust method to large distributions of reference values: program modifications and comparison of alternative computational methods.

Beasley CM Jr, Crowe B, Nilsson M, Wu L, Tabbey R, Hietpas RT, Dean RA, Horn PS.

J Biopharm Stat. 2019;29(3):516-528. doi: 10.1080/10543406.2019.1579223. Epub 2019 Feb 13.

PMID:
30757951
3.

Host-Microbe Interactions: Fungi Vol 46.

Dean RA, Rouxel T.

Curr Opin Microbiol. 2018 Dec;46:iii-v. doi: 10.1016/j.mib.2018.11.009. No abstract available.

PMID:
30553294
4.

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.

Willis BA, Sundell K, Lachno DR, Ferguson-Sells LR, Case MG, Holdridge K, DeMattos RB, Raskin J, Siemers ER, Dean RA.

Alzheimers Dement (N Y). 2018 Nov 9;4:652-660. doi: 10.1016/j.trci.2018.10.001. eCollection 2018.

5.

Assessing Burden of Care in the Patient With Cleft Lip and Palate: Factors Influencing Completion and Noncompletion of Nasoalveolar Molding.

Dean RA, Wainwright DJ, Doringo IL, Teichgraeber JF, Greives MR.

Cleft Palate Craniofac J. 2019 Jul;56(6):759-765. doi: 10.1177/1055665618811526. Epub 2018 Nov 19.

PMID:
30453775
6.

Derivation of cutoffs for the Elecsys® amyloid β (1-42) assay in Alzheimer's disease.

Shaw LM, Waligorska T, Fields L, Korecka M, Figurski M, Trojanowski JQ, Eichenlaub U, Wahl S, Quan M, Pontecorvo MJ, Lachno DR, Talbot JA, Andersen SW, Siemers ER, Dean RA.

Alzheimers Dement (Amst). 2018 Aug 11;10:698-705. doi: 10.1016/j.dadm.2018.07.002. eCollection 2018.

7.

Congenital aneurysm of the palmar digital artery: A case report and literature review.

Dean RA, Fleming SI, Zvavanjanja RC, Marques ES, Greives MR.

Radiol Case Rep. 2018 Oct 23;14(1):83-87. doi: 10.1016/j.radcr.2018.10.002. eCollection 2019 Jan.

8.

Silicone Migration and Late Hematoma following Silicone Implant Rupture: Case Report and Literature Review.

Dean RA, Glener AD, Thomas AB, Glener SR, Kurtovic S, Erdmann D.

Plast Reconstr Surg Glob Open. 2018 Aug 6;6(8):e1849. doi: 10.1097/GOX.0000000000001849. eCollection 2018 Aug.

9.

Inhibitory effects of cannabidiol on voltage-dependent sodium currents.

Ghovanloo MR, Shuart NG, Mezeyova J, Dean RA, Ruben PC, Goodchild SJ.

J Biol Chem. 2018 Oct 26;293(43):16546-16558. doi: 10.1074/jbc.RA118.004929. Epub 2018 Sep 14.

10.

Sequential Phosphopeptide Enrichment for Phosphoproteome Analysis of Filamentous Fungi: A Test Case Using Magnaporthe oryzae.

Oh Y, Franck WL, Dean RA.

Methods Mol Biol. 2018;1848:81-91. doi: 10.1007/978-1-4939-8724-5_7.

11.

Characterizing Small RNAs in Filamentous Fungi Using the Rice Blast Fungus, Magnaporthe oryzae, as an Example.

Raman V, Meyers BC, Dean RA, Donofrio NM.

Methods Mol Biol. 2018;1848:53-66. doi: 10.1007/978-1-4939-8724-5_5.

PMID:
30182228
12.

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.

Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K.

Alzheimers Dement. 2018 Oct;14(10):1313-1333. doi: 10.1016/j.jalz.2018.05.008. Epub 2018 Jun 23. Review.

PMID:
29940161
13.

Outcomes of microvascular flap reconstruction of the head and neck in patients receiving systemic immunosuppressive therapy for organ transplantation.

Schaverien MV, Dean RA, Myers JN, Fang L, Largo RD, Yu P.

J Surg Oncol. 2018 Jun;117(7):1575-1583. doi: 10.1002/jso.25035. Epub 2018 May 3.

PMID:
29723399
14.

To B or not to B: a tale of unorthodox chromosomes.

Soyer JL, Balesdent MH, Rouxel T, Dean RA.

Curr Opin Microbiol. 2018 Dec;46:50-57. doi: 10.1016/j.mib.2018.01.012. Epub 2018 Mar 23. Review. No abstract available.

PMID:
29579575
15.

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.

Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E.

N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.

16.

Comparative proteomic analysis between nitrogen supplemented and starved conditions in Magnaporthe oryzae.

Oh Y, Robertson SL, Parker J, Muddiman DC, Dean RA.

Proteome Sci. 2017 Nov 13;15:20. doi: 10.1186/s12953-017-0128-y. eCollection 2017.

17.

Editorial.

Dean RA.

Mol Plant Pathol. 2017 Aug;18(6):767. doi: 10.1111/mpp.12573. No abstract available.

PMID:
28685990
18.

A qualitative study on African immigrant and refugee families' experiences of accessing primary health care services in Manitoba, Canada: it's not easy!

Woodgate RL, Busolo DS, Crockett M, Dean RA, Amaladas MR, Plourde PJ.

Int J Equity Health. 2017 Jan 9;16(1):5. doi: 10.1186/s12939-016-0510-x.

19.

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.

Song L, Lachno DR, Hanlon D, Shepro A, Jeromin A, Gemani D, Talbot JA, Racke MM, Dage JL, Dean RA.

Alzheimers Res Ther. 2016 Dec 15;8(1):58.

20.

Survey of Parent Experiences in Prenatal Visits for Infants With Cleft Lip and Palate.

Greives MR, Anderson CL, Dean RA, Scerbo ML, Doringo IL, Bebbington MW, Teichgraeber JF.

Cleft Palate Craniofac J. 2017 Nov;54(6):668-673. doi: 10.1597/16-036. Epub 2016 Sep 15.

PMID:
27632760
21.

Examining ubiquitinated peptide enrichment efficiency through an epitope labeled protein.

Parker J, Oh Y, Moazami Y, Pierce JG, Loziuk PL, Dean RA, Muddiman DC.

Anal Biochem. 2016 Nov 1;512:114-119. doi: 10.1016/j.ab.2016.08.017. Epub 2016 Aug 22.

PMID:
27562526
22.

Quantile regression to characterize solanezumab effects in Alzheimer's disease trials.

Chen YF, Ma X, Sundell K, Alaka K, Schuh K, Raskin J, Dean RA.

Alzheimers Dement (N Y). 2016 Aug 17;2(3):192-198. doi: 10.1016/j.trci.2016.07.005. eCollection 2016 Sep.

23.

Identification and characterization of suppressors of plant cell death (SPD) effectors from Magnaporthe oryzae.

Sharpee W, Oh Y, Yi M, Franck W, Eyre A, Okagaki LH, Valent B, Dean RA.

Mol Plant Pathol. 2017 Aug;18(6):850-863. doi: 10.1111/mpp.12449. Epub 2016 Sep 20.

PMID:
27301772
24.

Revolutionizing Alzheimer's disease and clinical trials through biomarkers.

Mattsson N, Carrillo MC, Dean RA, Devous MD Sr, Nikolcheva T, Pesini P, Salter H, Potter WZ, Sperling RS, Bateman RJ, Bain LJ, Liu E.

Alzheimers Dement (Amst). 2015 Oct 3;1(4):412-9. doi: 10.1016/j.dadm.2015.09.001. eCollection 2015 Dec. Review.

25.

A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.

Hölttä M, Dean RA, Siemers E, Mawuenyega KG, Sigurdson W, May PC, Holtzman DM, Portelius E, Zetterberg H, Bateman RJ, Blennow K, Gobom J.

Alzheimers Res Ther. 2016 Mar 7;8(1):11. doi: 10.1186/s13195-016-0178-x.

26.

Comparative genome analysis and genome evolution of members of the magnaporthaceae family of fungi.

Okagaki LH, Sailsbery JK, Eyre AW, Dean RA.

BMC Genomics. 2016 Feb 25;17:135. doi: 10.1186/s12864-016-2491-y.

27.

The influence of funding sources on the scientific method.

Okagaki LH, Dean RA.

Mol Plant Pathol. 2016 Jun;17(5):651-3. doi: 10.1111/mpp.12380. No abstract available.

28.

Genome Sequences of Three Phytopathogenic Species of the Magnaporthaceae Family of Fungi.

Okagaki LH, Nunes CC, Sailsbery J, Clay B, Brown D, John T, Oh Y, Young N, Fitzgerald M, Haas BJ, Zeng Q, Young S, Adiconis X, Fan L, Levin JZ, Mitchell TK, Okubara PA, Farman ML, Kohn LM, Birren B, Ma LJ, Dean RA.

G3 (Bethesda). 2015 Sep 28;5(12):2539-45. doi: 10.1534/g3.115.020057.

29.

Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.

Raskin J, Cummings J, Hardy J, Schuh K, Dean RA.

Curr Alzheimer Res. 2015;12(8):712-22. Review.

30.

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.

Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R.

Alzheimers Dement. 2016 Feb;12(2):110-120. doi: 10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1.

31.

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.

Lucey BP, Gonzales C, Das U, Li J, Siemers ER, Slemmon JR, Bateman RJ, Huang Y, Fox GB, Claassen JA, Slats D, Verbeek MM, Tong G, Soares H, Savage MJ, Kennedy M, Forman M, Sjögren M, Margolin R, Chen X, Farlow MR, Dean RA, Waring JF.

Alzheimers Res Ther. 2015 Jul 29;7(1):53. doi: 10.1186/s13195-015-0136-z. eCollection 2015.

32.

The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.

Kang JH, Korecka M, Figurski MJ, Toledo JB, Blennow K, Zetterberg H, Waligorska T, Brylska M, Fields L, Shah N, Soares H, Dean RA, Vanderstichele H, Petersen RC, Aisen PS, Saykin AJ, Weiner MW, Trojanowski JQ, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):772-91. doi: 10.1016/j.jalz.2015.05.003. Review.

33.

Phosphoproteome Analysis Links Protein Phosphorylation to Cellular Remodeling and Metabolic Adaptation during Magnaporthe oryzae Appressorium Development.

Franck WL, Gokce E, Randall SM, Oh Y, Eyre A, Muddiman DC, Dean RA.

J Proteome Res. 2015 Jun 5;14(6):2408-24. doi: 10.1021/pr501064q. Epub 2015 May 15.

34.

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.

Hake A, Trzepacz PT, Wang S, Yu P, Case M, Hochstetler H, Witte MM, Degenhardt EK, Dean RA; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Aug;11(8):986-93. doi: 10.1016/j.jalz.2015.03.002. Epub 2015 Apr 24.

35.
36.

The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans.

May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ.

J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015.

37.

Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies.

Lachno DR, Evert BA, Maloney K, Willis BA, Talbot JA, Vandijck M, Dean RA.

J Alzheimers Dis. 2015;45(2):527-42.

PMID:
25547638
38.

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage.

Portelius E, Dean RA, Andreasson U, Mattsson N, Westerlund A, Olsson M, Demattos RB, Racke MM, Zetterberg H, May PC, Blennow K.

Alzheimers Res Ther. 2014 Nov 17;6(5-8):75. doi: 10.1186/s13195-014-0075-0. eCollection 2014.

39.

Draft Genome Sequence of the Plant-Pathogenic Soil Fungus Rhizoctonia solani Anastomosis Group 3 Strain Rhs1AP.

Cubeta MA, Thomas E, Dean RA, Jabaji S, Neate SM, Tavantzis S, Toda T, Vilgalys R, Bharathan N, Fedorova-Abrams N, Pakala SB, Pakala SM, Zafar N, Joardar V, Losada L, Nierman WC.

Genome Announc. 2014 Oct 30;2(5). pii: e01072-14. doi: 10.1128/genomeA.01072-14.

40.

Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014).

Siemers E, Dean RA, DeMattos RB, Hutton ML, Blennow K, Shaw LM, Holtzman DM.

Acta Neuropathol. 2014 Oct;128(4):609-10. doi: 10.1007/s00401-014-1332-9. Epub 2014 Aug 14. No abstract available.

PMID:
25120192
41.

Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays.

Dean RA, Fam HK, An J, Choi K, Shimizu Y, Jones SJ, Boerkoel CF, Interthal H, Pfeifer TA.

J Biomol Screen. 2014 Dec;19(10):1372-82. doi: 10.1177/1087057114546551. Epub 2014 Aug 12.

PMID:
25117203
42.

Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.

Chappell JC, Eisenhofer G, Owens MJ, Haber H, Lachno DR, Dean RA, Knadler MP, Nemeroff CB, Mitchell MI, Detke MJ, Iyengar S, Pangallo B, Lobo ED.

J Clin Psychopharmacol. 2014 Feb;34(1):9-16. doi: 10.1097/JCP.0000000000000061.

PMID:
24346757
43.

A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.

Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA, Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ.

Alcohol Clin Exp Res. 2014 Feb;38(2):511-20. doi: 10.1111/acer.12257. Epub 2013 Sep 6.

PMID:
24010675
44.

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.

Carrillo MC, Dean RA, Nicolas F, Miller DS, Berman R, Khachaturian Z, Bain LJ, Schindler R, Knopman D; Alzheimer's Association Research Roundtable.

Alzheimers Dement. 2013 Sep;9(5):594-601. doi: 10.1016/j.jalz.2013.05.1762.

PMID:
24007744
45.

Experimental evolution reveals genome-wide spectrum and dynamics of mutations in the rice blast fungus, Magnaporthe oryzae.

Jeon J, Choi J, Lee GW, Dean RA, Lee YH.

PLoS One. 2013 May 31;8(5):e65416. doi: 10.1371/journal.pone.0065416. Print 2013.

46.

An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function.

Henriksen K, Wang Y, Sørensen MG, Barascuk N, Suhy J, Pedersen JT, Duffin KL, Dean RA, Pajak M, Christiansen C, Zheng Q, Karsdal MA.

PLoS One. 2013 May 22;8(5):e64990. doi: 10.1371/journal.pone.0064990. Print 2013.

47.

Temporal analysis of the magnaporthe oryzae proteome during conidial germination and cyclic AMP (cAMP)-mediated appressorium formation.

Franck WL, Gokce E, Oh Y, Muddiman DC, Dean RA.

Mol Cell Proteomics. 2013 Aug;12(8):2249-65. doi: 10.1074/mcp.M112.025874. Epub 2013 May 12.

48.

Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab.

Lachno DR, Evert BA, Vanderstichele H, Robertson M, Demattos RB, Konrad RJ, Talbot JA, Racke MM, Dean RA.

J Alzheimers Dis. 2013;34(4):897-910. doi: 10.3233/JAD-122317.

PMID:
23302661
49.

In-depth analysis of the Magnaporthe oryzae conidial proteome.

Gokce E, Franck WL, Oh Y, Dean RA, Muddiman DC.

J Proteome Res. 2012 Dec 7;11(12):5827-35. doi: 10.1021/pr300604s. Epub 2012 Oct 29.

50.

Accurate discrimination of bHLH domains in plants, animals, and fungi using biologically meaningful sites.

Sailsbery JK, Dean RA.

BMC Evol Biol. 2012 Aug 24;12:154. doi: 10.1186/1471-2148-12-154.

Supplemental Content

Support Center